SUVAXYN

Main information

  • Trade name:
  • SUVAXYN PARVO/E
  • Pharmaceutical form:
  • Emulsion for injection
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • SUVAXYN PARVO/E
    Ireland
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • inactivated Porcine parvovirus vaccine + inactivated Erysipelothrix vaccine
  • Therapeutic area:
  • Pigs

Other information

Status

  • Source:
  • HMA - Europe
  • Authorization number:
  • ES/V/0100/001
  • Authorization date:
  • 28-12-2011
  • EU code:
  • ES/V/0100/001
  • Last update:
  • 09-08-2016

11-7-2018

ERYSENG (Laboratorios Hipra, S.A.)

ERYSENG (Laboratorios Hipra, S.A.)

ERYSENG (Active substance: Inactivated Erysipelothrix rhusiopathiae, strain R32E11) - Centralised - Yearly update - Commission Decision (2018)4523 of Wed, 11 Jul 2018

Europe -DG Health and Food Safety

4-7-2018

ERYSENG PARVO (Laboratorios Hipra, S.A.)

ERYSENG PARVO (Laboratorios Hipra, S.A.)

ERYSENG PARVO (Active substance: Inactivated porcine parvovirus, strain NADL-2 / Inactivated Erysipelothrix rhusiopathiae, strain R32E11) - Centralised - Yearly update - Commission Decision (2018) 4354 of Wed, 04 Jul 2018

Europe -DG Health and Food Safety

16-5-2018

Suvaxyn Aujeszky 783 + O/W (Zoetis Belgium S.A.)

Suvaxyn Aujeszky 783 + O/W (Zoetis Belgium S.A.)

Suvaxyn Aujeszky 783 + O/W (Active substance: Not available) - Centralised - Yearly update - Commission Decision (2018)3016 of Wed, 16 May 2018

Europe -DG Health and Food Safety

9-2-2018

Suvaxyn Circo (Zoetis Belgium S.A.)

Suvaxyn Circo (Zoetis Belgium S.A.)

Suvaxyn Circo (Active substance: Porcine circovirus vaccine (inactivated, recombinant)) - New authorisation - Commission Decision (2018)861 of Fri, 09 Feb 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/4242

Europe -DG Health and Food Safety